What Is The Main Reason That Hinders The Healthy And Sustainable Development Of The Pharmaceutical Industry?

In the pharmaceutical industry, a key area related to people's well-being, the healthy development of the market is not only related to the economic interests of enterprises, but also directly affects the drug safety and accessibility of patients. However, in recent years, the phenomenon of bottom price linked to the Internet and goods fleeing has become more and more rampant in the pharmaceutical terminal market, becoming the "Sword of Damocles" hanging over the heads of many pharmaceutical enterprises. These behaviors not only seriously disrupted the market order, forced enterprises into the quagmire of price war, damaged the industry image to a certain extent, and hindered the healthy and sustainable development of the pharmaceutical industry.

The term "fleeing" is no stranger in the pharmaceutical industry. It refers to the behavior of agents or dealers who violate the established agreement to sell products across regions or sell products online in violation of regulations. This behavior is like the "locust" of the market, eroding the health of the pharmaceutical industry. As a result, the interests of the agents and dealers in the fleeing areas are damaged, and the brand reputation is dusted in the disordered competition. In the long run, the market competitiveness of the enterprise will be seriously weakened, and even the survival foundation of the enterprise will be threatened.

The bottom price is another persistent problem. It dumps products at a price lower than the normal wholesale price through the online platform. It seems to bring short-term benefits to consumers, but it actually damages the entire industry ecology. Low price competition not only squeezes the profit space of enterprises, but also may cause quality and safety problems, because low price often means cost compression, which is often at the expense of product quality.

In the face of these challenges, although the senior management of the pharmaceutical industry has realized the harm and set up a special inspection department, unfortunately, these efforts seem to have failed to curb the spread of fleeing goods and bottom price. This makes people think deeply about the root of the problem? Is it the inevitable product of market development, or is there a regulatory loophole in some links, or is it acquiescence and connivance driven by interests?

To solve this problem, the pharmaceutical industry needs to start from many aspects, and it is necessary to build an effective management system. First, strengthen internal management, improve the agency and distribution network, clarify the rights and responsibilities of all parties, and improve the transparency of product circulation and reduce the space for fleeing goods through technical means such as two-dimensional code tracing, electronic supervision code, etc. Secondly, strengthen the cooperation and supervision with online platforms, standardize the product sales prices of e-commerce platforms, and crack down on the bottom price online behavior. At the same time, we should establish a sound reporting and reward mechanism, encourage internal and external forces to participate in supervision, and form a good atmosphere for the whole society to govern together.